APA (7th ed.) Citation

JD, P., SJ, K., A, N., J, B., I, G., DVT, C., . . . GL, B. (2022). Epacadostat Plus Pembrolizumab and Chemotherapy for Advanced Solid Tumors: Results from the Phase I/II ECHO-207/KEYNOTE-723 Study. The oncologist, 27(11), 905. https://doi.org/10.1093/oncolo/oyac174

Chicago Style (17th ed.) Citation

JD, Powderly, et al. "Epacadostat Plus Pembrolizumab and Chemotherapy for Advanced Solid Tumors: Results from the Phase I/II ECHO-207/KEYNOTE-723 Study." The Oncologist 27, no. 11 (2022): 905. https://doi.org/10.1093/oncolo/oyac174.

MLA (9th ed.) Citation

JD, Powderly, et al. "Epacadostat Plus Pembrolizumab and Chemotherapy for Advanced Solid Tumors: Results from the Phase I/II ECHO-207/KEYNOTE-723 Study." The Oncologist, vol. 27, no. 11, 2022, p. 905, https://doi.org/10.1093/oncolo/oyac174.